BIOLASE Q1 net revenue $10.1M (down 3% YoY); reiterates FY2024 guidance

BIOLASE, INC

2024-Q1 EPS reported -$0.36 revenue$10,131,000

Net revenue $10.1M, down 3% YoY; U.S. laser revenue down 22% to $2.7M.
Gross margin improved to 33% (up 1 ppt YoY); operating loss narrowed 15% to $4.5M.
Consumables revenue up 14% YoY; third strongest consumables quarter in company history.
Adjusted EBITDA loss improved 21% to $3.5M ($0.20 per share) vs. $4.4M a year ago.
Reaffirms FY2024 guidance: revenue $52-53M (6-8% growth) and positive Adjusted EBITDA.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

BIOLASE, INC reported first quarter ended March 31, 2024 results: revenue $10.1 million. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $10.1 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

resources necessary to maximize our growth opportunities and to enhance shareholder value.” First Quarter Financial Results Net revenue for the quarter ended March 31, 2024, was $10.1 million, a decrease of 3% compared to net revenue of $10.5 million for the quarter ended March 31, 2023. U.S. laser revenue was $2.7 million for the quarter ended March 31, 2024, a

View on SEC.gov

1047 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0000950170-24-058626

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.